Search this site powered by FreeFind




The News You Dont Want To Hear: Youve Got Breast Cancer


For many people being told that they have cancer is one of the most stressful times in their lives. Just as we think we have everything under control, something comes along that can shatter even the strongest of wills.

Out of the blue, in September 2002, Sara faced one of the biggest challenges of her life - her mother was diagnosed with breast cancer. Having nursed her mother through her illness, Sara took the step of having a mammogram just to make sure she herself was clear. All over Christmas she tried to put it to the back of her mind, but she couldn't help worrying.

On New Year's Eve 2002, she was horrified to learn that not only did she have breast cancer, but that it was a particularly aggressive form. Of course, Sara was very angry at first. She thought, Why me? It would have been better if I hadn't gone for a mammogram. She was also very scared. She said, When someone says, You have cancer, you immediately think you're going to die. I have to wait six weeks before my surgery and I have no idea how I will stay sane until then. What on earth am I going to do?"

After a few very bleak days, Sara decided she was determined not to give in too easily. Her mother had, after all, fought the disease, so she, too, could do the same. When she was calm enough to answer her question What on earth am I going to do? several answers came to her, as she was walking her dog.

Find out as much as possible about breast cancer.

Talk to other people who have faced similar situations.

Be realistic about what she could change and what she needed to accept.

When Sara opened her eyes and started to believe that she had choices, she was amazed at the different ideas that popped into her head. She discovered practical ways to prepare her body and mind prior to her mastectomy and reconstructive surgery. She was able to make a number of choices in her life, including exercise, changing her diet and learning how to chill out with meditation.

By the time Sara went into hospital in February, her frame of mind had shifted from a very negative one to that of how she could take control of her life. She said, I can't stop the cancer running through my body but I can change how I deal with it. It's taking over my body but it doesn't have to take over my mind. I can control how I deal with it.

Sara is certain that her excessive workload, poor nutrition and lack of exercise had taken a toll on her body and were contributing factors to her state of health. She sees her illness as a new chapter in her life rather than the end of it. As well as conventional medicine, Sara has also discovered the power of laughter. "It is impossible to laugh and feel stressed at the same time. I think laughing brings about release."

If you are feeling stressed you might not feel like laughing. But laughter really is the best medicine. As Sara pointed out, it is difficult to laugh and feel anxious at the same time! Try it! How do you feel when you have a really good laugh? As soon as you start to laugh, the power of the stress is lessened.

I have recently been very involved in setting up a charity, Clowns in the Sky, which supports children suffering from brain tumours. Children with tumours spend many weeks in hospital undergoing painful treatment and we have found that bringing some fun into their lives makes a huge difference to their well-being. If they can laugh, so can you!

My favourite films are The Full Monty, Bridget Jones and Hitch. Why? Because they make me laugh!

This Christmas we tried out a really funny game. Try saying "purple sprouting broccoli" with your lips over your teeth; it is almost impossible to do. You will laugh with frustration that no one can understand you and others will laugh at you because you look and sound so silly. Don't worry, everyone including you will be laughing!

Is everything perfect for Sara? Of course not. Her initial surgery was successful although she was diagnosed with breast cancer again a few months ago. The fear that the cancer might return again has always been the hardest thing for her to deal with and it is something she thinks about every day. But she feels much more in control of certain aspects of her life. She is trying to focus on what she can change, just a day at a time. She still finds the visits to hospital very stressful, but she doesn't allow herself to dwell on negative aspects of her illness for too long as she has found it very counterproductive.

Sara didn't have any choice about having breast cancer. She did have choices, however, about how she chose to deal with life each day.

You may not be able to influence and overcome every stressful situation, but you can take charge over how you respond.

If you are facing a major change and finding life very stressful, what changes can you make to how you view the situation today?

If you want to manage stress in your life, you need to begin with yourself.

None of us are able to predict the future, but we can make the present better if we choose to.

What makes you laugh? Do you have a favourite video, a story, a joke or a friend who helps you to lighten up?

Focus on what you can change and you will start to feel more in control of your life.

Carolyn Matheson is a nationally recognized Coach, Speaker and Author of "Yes to Less Stress."

Carolyn is a Master Certified Coach, and works with executives and their teams across the world. She has pioneered an innovative approach to coaching, combining many years of high performance coaching with a holistic approach to work/life balance and has coached hundreds of leaders and their teams. Her experience as a presenter, both nationally and internationally, spans 20 years, with clients currently in Europe, Australia, the Middle and Far East, and the USA.

Her new book, Yes to Less Stress is available online at her website, http://www.areustressed.com


MORE RESOURCES:
Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal Cancer, the Seattle Post-Intelligencer reports (Paulson, Seattle Post-Intelligencer, 8/24).

A new promising enzyme target for a specific type of breast cancer, Brk, has been identified in research published on August 21, 2008 in the Proceedings of the National Academy of Sciences (PNAS.) In a specific subset of breast cancer patients, the tumor cells produce high levels of the protein ErbB2 (also called HER2) which pushes the cells to proliferate without limit, a characteristic common of all cancers.

The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders. Established by students, for students, AMSA Academy takes medical students through the core competencies of leadership and project implementation, while building on key principles of important topics in medicine. There are currently 22 programs offered.

Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel. An article on the study titled "Breast Cancer, Psychological Distress and Life Events among Young Women," was just published in the British journal BMC Cancer (8:245, August 2008).

Feelings of happiness and optimism play a positive role against breast cancer. Research published in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease.

New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. The findings suggest a cellular mechanism for the correlation between human breast tissue density and tumor aggressiveness.

Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered.

A new study published on bmj.com argues that for older women, health related quality of life can be improved by hormone replacement therapy (HRT). The authors recommend that HRT guidelines should be revised with this most current evidence taken into consideration. Earlier studies have shown that HRT has the potential for general improvements in quality of life measures - how patients feel or function.

Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected. The researchers also deduced that this molecule -- called largazole -- acts on cells through the same chemical mechanism as other anti-cancer compounds on the market or in clinical trials.

Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. The researchers are combining organic chemistry, computer-aided design and molecular biology techniques in developing and testing pharmaceutical compounds that can fight breast and prostate cancer cells.

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in a global Phase 3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer.

Advocates, including those for breast cancer patients, are concerned about their relationship with pharmaceutical company Genentech following Roche's bid for the company, the

A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state. "Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.D.

Women who survive breast cancer for at least five years after treatment have an 89% chance that they will not have a recurrence of the cancer after 10 years and an 81% chance after 15 years, according to a study published online Tuesday in the Journal of the National Cancer Institute,

Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours. Dr Alexis Willett, Policy Manager at Breakthrough Breast Cancer, says: "Breakthrough welcomes any research which investigates new uses for existing treatments to help benefit people with breast cancer.

An article published in The Lancet Oncology reports that postmenopausal women with breast cancer who are on endocrine treatment are likely to experience arthralgia and arthritis (joint symptoms) if they previously have used hormone replacement therapy (HRT), received a hormone-receptor positive tumor diagnosis, undergone chemotherapy, received treatment with anastrozole versus tamoxifen, or been obese.

Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients.

Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.

Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.

Famous names from the fashion, television, radio and music industries have come together to back Fashion Targets Breast Cancer® (FTBC) UK in an advertising campaign which subtly plays on the topic of celebrity charity endorsement. Natalie Imbruglia, Anna Friel, Alan Carr, Edith Bowman and Twiggy have been shot by acclaimed photographer Rankin wearing their FTBC T-shirts with pride for the campaign from leading charity Breakthrough Breast Cancer which aims to raise £1m.

US researchers estimated that the risk of relapse for breast cancer patients who were cancer-free for five years after systemic therapy (chemotherapy, hormone therapy, or both, as well as surgery) was not negligible although it was probably lower than many people realized.

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer.

American Airlines, the world's largest airline, and Susan G. Komen for the Cure®, the world's largest breast cancer organization, announced an expanded partnership with the unveiling of two specially co-branded aircraft, an American Airlines Boeing 757 and an American Eagle Embraer 145, each incorporating the renowned vivid pink-ribbon motif.

Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase I/II, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with a paclitaxel/bevacizumab regimen in this patient population.

A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome (CS) and related disorders.

home | site map| privacy policy
© 2008, Celerity Consultants, Mumbai, India, All Rights Reserved